TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 3 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $294,763 | +13.7% | 19,054 | +13.4% | 0.00% | +50.0% |
Q2 2023 | $259,338 | +156127.7% | 16,800 | +58.1% | 0.00% | – |
Q4 2022 | $166 | -99.9% | 10,629 | +0.4% | 0.00% | -100.0% |
Q3 2022 | $137,000 | -94.3% | 10,588 | -93.8% | 0.00% | -90.5% |
Q2 2022 | $2,388,000 | +23.9% | 170,067 | +26.3% | 0.02% | +40.0% |
Q1 2022 | $1,928,000 | +53.3% | 134,682 | +46.0% | 0.02% | +66.7% |
Q4 2021 | $1,258,000 | -36.4% | 92,243 | -23.7% | 0.01% | -30.8% |
Q3 2021 | $1,979,000 | +156.3% | 120,847 | +163.4% | 0.01% | +85.7% |
Q2 2021 | $772,000 | +23.9% | 45,874 | +34.4% | 0.01% | +16.7% |
Q1 2021 | $623,000 | +52.0% | 34,129 | +51.3% | 0.01% | +50.0% |
Q4 2020 | $410,000 | +376.7% | 22,553 | +370.8% | 0.00% | +300.0% |
Q2 2020 | $86,000 | – | 4,790 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |